The Board of Directors approved Q2 2022
consolidated financial statements.
Date of events
2022/08/04
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/08/04
2.Date of approval by the audit committee:2022/08/04
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3,382,621
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):740,566
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):308,689
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):459,855
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):369,907
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):308,122
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.18
11.Total assets end of the period (thousand NTD):16,014,344
12.Total liabilities end of the period
(thousand NTD):6,199,849
13.Equity attributable to owners of parent end of the
period (thousand NTD):7,810,783
14.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Excelsior Medical Co. Ltd. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 09:36:02 UTC.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.